| Dr William S Long, DPM | |
|
801 Se Main Street, Simpsonville, SC 29681-3226 | |
| (864) 399-9070 | |
| (864) 399-9664 |
| Full Name | Dr William S Long |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 15 Years |
| Location | 801 Se Main Street, Simpsonville, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447486980 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 617 (South Carolina) | Primary |
| 213E00000X | Podiatrist | SC006156 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Hillcrest Hospital | Simpsonville, SC | Hospital |
| Prisma Health Greer Memorial Hospital | Greer, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upstate Podiatry Group Pa | 5698919694 | 4 |
News Archive
Diversified Information Technologies today announced a three-year agreement with Blue Cross of Northeastern Pennsylvania to help the insurer streamline its group enrollment processes.
Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.
Exposure to light and possibly photosynthesis itself could be helping disease-causing bacteria to be internalized by lettuce leaves, making them impervious to washing, according to research published in the October issue of the journal Applied and Environmental Microbiology.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
| Provider Name | Abbeville County Memorial Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649816216 PECOS PAC ID: 7719891506 Enrollment ID: O20031117000214 |
News Archive
Diversified Information Technologies today announced a three-year agreement with Blue Cross of Northeastern Pennsylvania to help the insurer streamline its group enrollment processes.
Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.
Exposure to light and possibly photosynthesis itself could be helping disease-causing bacteria to be internalized by lettuce leaves, making them impervious to washing, according to research published in the October issue of the journal Applied and Environmental Microbiology.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
| Provider Name | Upstate Podiatry Group Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1144660036 PECOS PAC ID: 5698919694 Enrollment ID: O20130912000619 |
News Archive
Diversified Information Technologies today announced a three-year agreement with Blue Cross of Northeastern Pennsylvania to help the insurer streamline its group enrollment processes.
Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.
Exposure to light and possibly photosynthesis itself could be helping disease-causing bacteria to be internalized by lettuce leaves, making them impervious to washing, according to research published in the October issue of the journal Applied and Environmental Microbiology.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William S Long, DPM 801 Se Main Street, Simpsonville, SC 29681-3226 Ph: (864) 399-9070 | Dr William S Long, DPM 801 Se Main Street, Simpsonville, SC 29681-3226 Ph: (864) 399-9070 |
News Archive
Diversified Information Technologies today announced a three-year agreement with Blue Cross of Northeastern Pennsylvania to help the insurer streamline its group enrollment processes.
Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.
Exposure to light and possibly photosynthesis itself could be helping disease-causing bacteria to be internalized by lettuce leaves, making them impervious to washing, according to research published in the October issue of the journal Applied and Environmental Microbiology.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
› Verified 8 days ago
Upstate Podiatry Group, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 801 Se Main St, Simpsonville, SC 29681 Phone: 864-399-9070 Fax: 864-399-9664 | |
Upstate Podiatry Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 114b Hospital Dr, Simpsonville, SC 29681 Phone: 864-399-9070 Fax: 864-399-9664 |